Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery

Neurologia Medico-Chirurgica

Volumn 47, Issue 10, 2007, Pages 462-467

  Fiss, Ingo ^a   Danne, Marco ^a   Stendel, Ruediger ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bleeding; Disseminated intravascular coagulation; Fibrinogen; Hemostasis; Neurosurgery; Thrombin

Indexed keywords

FIBRINOGEN; GELATIN; HEMOSTATIC AGENT; SEALANT; THROMBIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING PARAMETERS; DISEASE SEVERITY; FEMALE; GLIOBLASTOMA; HEMANGIOBLASTOMA; HEMOSTASIS; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEUROSURGERY; PITUITARY MACROADENOMA; POSTOPERATIVE COMPLICATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BRAIN; DRUG COMBINATIONS; FEMALE; FIBRINOGEN; GELATIN SPONGE, ABSORBABLE; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; NEUROSURGERY; RETROSPECTIVE STUDIES; SKULL; THROMBIN; TREATMENT OUTCOME;

EID: 35648977059     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.47.462     Document Type: Article

References (36)

1. Bak JB, Singh A, Shekarriz B: Use of gelatin matrix tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy. J Urol 171: 780-782, 2004
2. Baumann A, Caversaccio M: Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin based agent (FloSeal). Rhinology 41: 244-249, 2003
3. Buchta C, Hedrich HC, Macher M, Höcker P, Redl H: Biochemical characterization of autologous fibrin sealants produced by CryoSeal® and Vivostat® in comparison to the homologous fibrin sealant product Tissucol/Tisseel®. Biomaterials 26: 6233-6241, 2005
4. Chandra RK, Conley DB, Haines GK, Kern RC: Long-term effects of FloSeal packing after endoscopic sinus surgery. Am J Rhinol 19: 240-243, 2005
5. Chandra RK, Conley DB, Kern RC: The effect of FloSeal on mucosal healing after endoscopic sinus surgery: a comparison with thrombin-soaked gelatin foam. Am J Rhinol 17: 51-55, 2003
6. Destaing F, Duzer A, Ferrand B: Determination of fibrinogen by the Von Clauss coagulation micromethod. Pathol Biol (Paris) 8: 1615-1621, 1960
7. Ellegala DB, Maartens NF, Laws ER: Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 51: 513-516, 2002
8. Esposito F, Dusick JR, Fatemi N, Kelly DF: Graded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery. Neurosurgery 60 Suppl 2: 295-303, 2006
9. Evans C, Tippins E: Emergency treatment of anaphylaxis. Accid Emerg Nurs 13: 232-237, 2005
10. Heesen M, Winking M, Kemkes-Matthes B, Deinsberger W, Dietrich GV, Matthes KJ, Hempelmann G: What the neurosurgeon needs to know about the coagulation system. Surg Neurol 47: 32-34, 1997
11. Jorgensen S, Bascom DA, Partsafas A, Wax MK: The effect of 2 sealants (FloSeal and Tisseel) on fasciocutaneous flap revascularization. Arch Facial Plast Surg 5: 399-402, 2003
12. Kaushik V, Tahery J, Malik TH, Jones PH: New surgical adjuncts in the treatment of rhinophyma: the microdebrider and FloSeal. J Laryngol Otol 117: 551-552, 2003
13. Kraus H: [Fibrinolytic activity of brain tumors and treatment of bleeding diathesis]. Schweiz Arch Neurol Neurochir Psychiatr 108: 27-31, 1971 (Ger)
14. Lambert CJ, Marengo-Rowe AJ, Leveson JE, Green RH, Thiele JP, Geisler GF, Adam M, Mitchel BF: The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate. Ann Thorac Surg 28: 440-444, 1979
15. Lapointe LA, Von Rueden KT: Coagulopathies in trauma patients. AACN Clin Issues 13: 192-203, 2002
16. Lawson JH: The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost 32 Suppl 1: 98-110, 2006
17. L'Esperance JO, Sung JC, Marguet CG, Maloney ME, Springhart WP, Preminger GM, Albala DM: Controlled survival study of the effects of Tisseel or a combination of FloSeal and Tisseel on major vascular injury and major collecting-system injury during partial nephrectomy in a porcine model. J Endourol 19: 1114-1121, 2005
18. Losche W: Platelets and tissue factor. Platelets 16: 313-319, 2005
19. Lubaroff DM, Konety B, Link BK, Ratliff TL, Madsen T, Shannon M, Ecklund D, Williams RD: Clinical protocol: phase I study of an adenovirus/prostate- specific antigen vaccine in men with metastatic prostate cancer. Hum Gene Ther 17: 220-229, 2006
20. McDuffie FC, Giffin C, Niedringhaus R, Mann KG, Owen CA, Bowie EJ, Peterson J, Clark G, Hunder GG: Prothrombin, thrombin and prothrombin fragments in plasma of normal individuals and of patients with laboratory evidence of disseminated intravascular coagulation. Thromb Res 16: 759-773, 1979
21. Murat FJL, Ereth MH, Dong Y, Piedra MP, Gettman MT: Evaluation of microporous polysaccharide hemispheres as a novel hemostatic agent in open partial nephrectomy: favourable experimental results in the porcine model. J Urol 172: 1119-1122, 2004
22. Muskett A, Barber WH, Lineaweaver WC: The Plastic surgeon's guide to drugs affecting hemostasis. Ann Plast Surg 54: 570-576, 2005
23. Oldenburg J, Hartfelder HJ: [Blood coagulation and hemorrhagic diathesis]. Pharm Unserer Zeit 35: 20-28, 2006 (Ger)
24. Oz MC, Cosgrove DM, Badduke BR, Hill JD, Flannery MR, Palumbo R, Topic N: Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 69: 1376-1382, 2000
25. Oz MC, Rondinone JF, Shargill NS: FloSeal Matrix: new generation topical hemostatic sealant. J Card Surg 18: 486-493, 2003
26. Palmer JD, Francis DA, Francis JL: Meningioma-induced fibrinolysis. J Neurol Neurosurg Psychiatry 57: 388, 1994 (abstract)
27. Palmer JD, Francis JL, Pickard JD, Iannotti F: The efficacy and safety of aprotinin for hemostasis during intracranial surgery. J Neurosurg 98: 1208-1216, 2003
28. Partsafas AW, Bascom DA, Jorgensen SA, Wax MK: Effects of Tisseel and FloSeal on primary ischemic time in a rat fasciocutaneous free flap model. Laryngoscope 114: 301-304, 2004
29. Renkens KL Jr, Paynor TD, Leipzig TJ, Feuer H, Morone MA, Koers JM, Lawson KJ, Lentz R, Shuey H, Conaway GL, Andersson GB, An HS, Hickey M, Rondinone JF, Shargill NS: A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine 26: 1645-1650, 2001
30. Reuthebuch O, Lachat ML, Vogt P, Schurr U, Turina M: FloSeal: a new hemostyptic agent in peripheral vascular surgery. Vasa 29: 204-206, 2000
31. Richter F, Tullmann ME, Turk I, Deger S, Roigas J, Wille A, Schnorr D: [Improvement of hemostasis in laparoscopic and open partial nephrectomy with gelatin thrombin matrix (FloSeal)]. Urologe A 42: 338-346, 2003 (Ger, with Eng abstract)
32. Sabel M, Stummer W: The use of local agents: Surgicel and Surgifoam. Eur Spine J 13 Suppl 1: S97-S101, 2004
33. Tice DA, Reed GE, Clauss RH: Hemorrhage due to fibrinolysis occurring with open-heart operations. J Thorac Cardiovasc Surg 46: 673-679, 1963
34. User HM, Nadler RB: Applications of FloSeal in nephron-sparing surgery. Urology 62: 342-343, 2003
35. van Dijk JH, Pes PL: Haemostasis in laparoscopic partial nephrectomy: current status. Minim Invasive Ther Allied Technol 16: 31-44, 2007
36. Voormolen JH, Ringers J, Bots GT, van der Heide A, Hermans J: Hemostatic agents: brain tissue reaction and effectiveness. A comparative animal study using collagen fleece and oxidized cellulose. Neurosurgery 20: 702-709, 1987